Second Ebola vaccine introduced in the DRC
It said the new vaccine, produced by a Belgian subsidiary of Johnson & Johnson, is aimed at protecting 50 000 people over a period of four months
Sud Kivu
You are viewing the M&G archive site.
Go to mg.co.za →
The Mail & Guardian has a new home.
Visit the new mg.co.za →